SNAPC1 Activators are a set of chemical compounds that augment the functional activity of SNAPC1 by modulating various signaling pathways that indirectly influence its role in snRNA gene transcription. Compounds such as Forskolin, Rolipram, Isoproterenol, IBMX, 8-Br-cAMP, and BAY 60-7550 operate primarily through the elevation of intracellular cAMP levels, which leads to the activation of PKA. This kinase, in turn, phosphorylates transcription factors that work synergistically with SNAPC1, enhancing its ability to initiate transcription. Additionally, PMA through PKC activation, and Sildenafil via cGMP accumulation with downstream effects on the cAMP/PKA pathway, also contribute to the optimization of SNAPC1's transcriptional regulatory functions. Anisomycin and SP600125 modulate the JNK pathway, which can adjust the activation state of transcription factors involved with SNAPC1, thereby indirectly enhancing its activity.
Furthermore, FSK-L89, like Forskolin, activates adenylyl cyclase to raise cAMP levels and subsequently PKA activity, indirectly leading to an upregulation of SNAPC1's transcriptional activity. Vinpocetine adds to this regulatory milieu by inhibiting PDE1, which results in increased levels of both cAMP and cGMP, potentiating a cascade that eventually increases PKA activity. This kinase can then facilitate the phosphorylation of transcriptional machinery that cooperates with SNAPC1, further boosting its transcriptional regulation of snRNA genes. The precise modulation of these signaling pathways by the listed activators culminates in the enhanced functional activity of SNAPC1, reinforcing its essential role in the initiation and regulation of snRNA gene transcription without the need for direct activation or upregulation of its expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate transcription factors that enhance the activity of SNAPC1 in the initiation of snRNA transcription. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, preventing cAMP breakdown. This results in increased PKA activity, indirectly promoting the transcriptional activity of SNAPC1 by enhancing the phosphorylation of associated transcription factors. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenoceptor agonist leading to increased cAMP and subsequent activation of PKA. PKA can then enhance the function of SNAPC1 by phosphorylating components of the transcription machinery. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which increases intracellular levels of cAMP and activates PKA. PKA indirectly boosts SNAPC1 activity by phosphorylating factors involved in snRNA gene transcription. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA. PKA then indirectly enhances SNAPC1 function by phosphorylation of transcription factors involved in the regulation of snRNA gene transcription mediated by SNAPC1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC). Activated PKC may enhance the phosphorylation of proteins that interact with SNAPC1, thus promoting SNAPC1's role in transcription initiation. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
BAY 60-7550 is a selective PDE2 inhibitor, raising cAMP levels and thus activating PKA. PKA can enhance SNAPC1 activity by phosphorylating transcriptional regulators involved in snRNA gene transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator which can indirectly enhance SNAPC1's role in transcription by influencing the activation of transcription factors that cooperate with SNAPC1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor which can paradoxically upregulate certain transcriptional pathways, potentially enhancing the function of SNAPC1 by altering the balance of transcription factor activity. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine is a PDE1 inhibitor that increases cAMP and cGMP levels, which indirectly increases PKA activity and could enhance SNAPC1's role in the transcription of snRNA genes. | ||||||